Results
1 -
10 of
10
(Click
here to explore results)
- Macrocycles in Drug Discovery, CHAPTER 7 Linear and Macrocyclic Hepatitis C Virus Protease Inhibitors: Inhibitor Design and Macrocyclization Strategies for HCV Protease and Related Targets. Wieslaw M. Kazmierski, Richard L. Jarvest, Jacob J. Plattner, Xianfeng Li
, 2015
, Pages 235-282
- Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation, Chapter 7 Isoquinolines. Esther S. Roesch
, 2016
, Pages 147-213
- Macrocycles in Drug Discovery, Subject Index
, 2015
, Pages 487-499
- Successful Strategies for the Discovery of Antiviral Drugs, Subject index
, 2013
, Pages 509-534
- Successful Strategies for the Discovery of Antiviral Drugs, CHAPTER 1 Discovery and Clinical Validation of HCV Inhibitors Targeting the NS5A Protein. Makonen Belema, Nicholas A. Meanwell, John A. Bender, Omar D. Lopez, Piyasena Hewawasam, David R. Langley
, 2013
, Pages 3-28
- Macrocycles in Drug Discovery, Contents
, 2015
, Pages P013-P020
- Successful Strategies for the Discovery of Antiviral Drugs, CHAPTER 7 HCV NS3/4a Protease Inhibitors: Simeprevir (TMC‐435350), Vaniprevir (MK‐7009) and MK‐5172. John A. McCauley, Michael T. Rudd, Nigel J. Liverton
, 2013
, Pages 189-247
- Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation, Subject Index
, 2016
, Pages 459-468
- Chemistry, Biological Activities and Therapeutic Applications of Medicinal Plants in Ayurveda, Chapter 13 Ayurvedic Knowledge Inspired Approach to Modern Drug Discovery. Premalatha Balachandran
, 2023
, Pages 325-373
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 2, CHAPTER 1 In Silico Approaches for Drug Repurposing for SARS-CoV-2 Infection. Sudhir A. Kulkarni, Kundan Ingale
, 2022
, Volume 2
, Pages 1-80